Indride MP 2mg/500mg/15mg Tablet SR
Marketer
Indmark Biotech Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Indride MP 2mg/500mg/15mg Tablet SR
Metformin/Pioglitazone/Sitagliptin extended-release tablets (2mg/500mg/15mg) are a triple-combination medication designed to manage blood glucose. This medication, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It improves insulin effectiveness, thus reducing blood sugar. Dosage and duration should strictly adhere to your physician's instructions. Administer with food to mitigate gastrointestinal discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume the usual schedule. Never double the dose. Overdosing can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic agents, alcohol consumption, or meal skipping may increase hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, inform your doctor of any kidney, liver, or heart conditions. Pregnant or lactating individuals require prior medical consultation. Kidney function tests will be conducted before initiating therapy. Limit alcohol consumption to minimize the risk of side effects.
Primary Ingredients of Indride MP 2mg/500mg/15mg Tablet SR
No information provided. Therefore, no text can be rewritten.
Uses of Indride MP 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Indride MP 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet whole; avoid chewing, crushing, or breaking it. The Indride MP 2mg/500mg/15mg Extended-Release tablet should be administered with a meal.
Common Side effects of Indride MP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Indride MP 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Consume the Indride MP 2mg/500mg/15mg Extended-Release tablet with food.
How Indride MP 2mg/500mg/15mg Tablet SR works:
Indride MP 2mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach enhances blood glucose management when single or dual medication regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts via multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Indride MP 2mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Indride MP 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Indride MP tablets (2mg/500mg/15mg) are likely not suitable for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Indride MP 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Indride MP 2mg/500mg/15mg SR tablets. Physician consultation is necessary. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Indride MP 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Indride MP 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Indride MP 2mg/500mg/15mg Tablet SR :
Should you forget to take your Indride MP 2mg/500mg/15mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Indride MP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently